As of August 2024 Glenmark Life Sciences has 122.53M shares outstanding, a increase of 4.26% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 122.53M | 4.26% |
2022 | 117.53M | -4.08% |
2021 | 122.53M | 0.00% |
2020 | 122.53M | - |